Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
1048/25
Lacuna Pharma Pty Ltd
Not applicable (submitted trial is a BE study in healthy subjects).
1 trial -
1062/25
Laboratorios Tillomed Spain S.L.U
Bioavailability study in healthy volunteers under fasting conditions.
1 trial -
1245-0358
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1305-0039
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1305-0113
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1305-0119
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1366-0042
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1368-0151
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1378-0024
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1378-0025
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1378-0043
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1397-0021
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1397-0022
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1397-0029
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1404-0009
Boehringer Ingelheim
Renal impairment (mild, moderate and severe), Healthy
1 trial -
1404-0011
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1404-0015
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1404-0074
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1404-0099
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1404-0103
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1404-0118
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1434-0005
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
1434-0006
Boehringer Ingelheim
healthy volunteer trial
1 trial -
1434-0021
Boehringer Ingelheim
Healthy volunteer trial
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.